Review Article
Volume 11 Issue 7 - 2022
The Biophenols behind the Mediterranean Diet
RE Carlson1 and JA von Fraunhofer2*
1Executive Director, Research and Analytical Sciences, D. Gary Young Research Institute, Lehi, UT, USA
2Professor Emeritus, University of Maryland, Baltimore, MD, USA
*Corresponding Author: JA von Fraunhofer, Professor Emeritus, University of Maryland, Baltimore, MD, USA.
Received: May 22, 2022; Published: June 29, 2022


The chemistry and bioactivity of the biophenols hydroxytyrosol, tyrosol and oleuropein, present in olive oil, are reviewed. In particular, the scientific literature regarding their antioxidant, antimicrobial, anticancer and neuroprotective activities is discussed in detail. The identified bioactivities of these compounds are astonishing and clearly demonstrate and validate the overwhelming health benefits arising from the consumption of olive oil in the Mediterranean diet.

Keywords: Bioactive Components; Olive Oil; Mediterranean Diet


  1. Carlson RE and Von Fraunhofer JA. “Olive oil: Nature’s panacea”. In Press.
  2. Bellumori M., et al. “The EFSA health claim on olive oil polyphenols: acid hydrolysis validation and total hydroxytyrosol and tyrosol determination in Italian virgin olive oils”. Molecules11 (2019): 2179.
  3. López-Huertas E., et al. “Olive oil varieties and ripening stages containing the antioxidants hydroxytyrosol and derivatives in compliance with EFSA health claim”. Food Chemistry 342 (2021): 128291.
  4. Carlson RE and Von Fraunhofer JA. “Oleocanthal and human health – An overview”. EC Nutrition3 (2022): 40-44.
  5. Marković AK., et al. “Hydroxytyrosol, tyrosol and derivatives and their potential effects on human health”. Molecules10 (2019): 1-29.
  6. Haloui E., et al. “Hydroxytyrosol and oleuropein from olive leaves: Potent anti-inflammatory and analgesic activities”. Journal of Food, Agriculture and Environment3-4 (2011): 128-133.
  7. Bernini R., et al. “Naturally occurring hydroxytyrosol: Synthesis and anticancer potential”. Current Medicinal Chemistry5 (2013): 655-670.
  8. Hu T., et al. “Hydroxytyrosol and its potential therapeutic effects”. Journal of Agricultural and Food Chemistry7 (2014): 1449-1455.
  9. Aydar AY., et al. “Effects of hydroxytyrosol on human health”. EC Nutrition4 (2017): 147-157.
  10. Wani TA., et al. “Olive oil and its principal bioactive compound: hydroxytyrosol – A review of the recent literature”. Trends in Food Science and Technology 77 (2018): 77-90.
  11. Tutino V., et al. “Antiproliferative, antioxidant and anti-inflammatory effects of hydroxytyrosol on human hepatoma HepG2 and Hep3B cell lines”. Anticancer Research12 (2012): 5371-5377.
  12. Fuccelli R., et al. “Hydroxytyrosol exerts anti-inflammatory and anti-oxidant activities in a mouse model of systemic inflammation”. Molecules12 (2018): 3212.
  13. Crea R., et al. “Anti-inflammatory activity of hydroxytyrosol Inhibition of cytokine production in a Parkinson’s model system of neuroinflammation”. European Journal of Nutrition2 (2012): 26-29.
  14. Vilaplana-Pérez C., et al. “Hydroxytyrosol and potential uses in cardiovascular diseases, cancer, and AIDS”. Frontiers in Nutrition 1 (2014): 18.
  15. D’Angelo C., et al. “Wide biological role of hydroxytyrosol: Possible therapeutic and preventive properties in cardiovascular diseases”. Cells9 (2020): 1932-1951.
  16. Peyrol J., et al. “Hydroxytyrosol in the prevention of the metabolic syndrome and related disorders”. Nutrients3 (2017): 306-324.
  17. Bertelli M., et al. “Hydroxytyrosol: A natural compound with promising pharmacological activities”. Journal of Biotechnology 309 (2020): 29-33.
  18. Khymenets O., et al. “Antioxidant activities of hydroxytyrosol main metabolites do not contribute to beneficial health effects after olive oil ingestion”. Drug Metabolism and Disposition9 (2010): 1417-1421.
  19. Bisignano G., et al. “On the in vitro antimicrobial activity of oleuropein and hydroxytyrosol”. Journal of Pharmacy and Pharmacology8 (1999): 971-974.
  20. Romero C., et al. “In vitro activity of olive oil polyphenols against Helicobacter pylori”. Journal of Agricultural and Food Chemistry3 (2007): 680-686.
  21. Ghalandari M., et al. “Antimicrobial effect of hydroxytyrosol, hydroxytyrosol acetate and hydroxytyrosol oleate on Staphylococcus Aureus and Staphylococcus Epidermidis”. Electronic Journal of General Medicine4 (2018): 1-7.
  22. Tuck KL and Hayball PJ. “Major phenolic compounds in olive oil: metabolism and health effects”. The Journal of Nutritional Biochemistry11 (2002): 636-644.
  23. Rodríguez-Morató J., et al. “Metabolic disposition and biological significance of simple phenols of dietary origin: Hydroxytyrosol and tyrosol”. Drug Metabolism Reviews2 (2016): 218-236.
  24. Boronat A., et al. “Cardiovascular benefits of tyrosol and its endogenous conversion into hydroxytyrosol in humans. A randomized, controlled trial”. Free Radical Biology and Medicine 143 (2019): 471-481.
  25. Plotnikov MB and Plotnikova TM. “Tyrosol as a neuroprotector: Strong effects of a “weak” antioxidant”. Current Neuropharmacology4 (2021): 434-448.
  26. Soldevila-Domenech N., et al. “Generation of the antioxidant hydroxytyrosol from tyrosol present in beer and red wine in a randomized clinical trial”. Nutrients9 (2019): 2241-2254.
  27. Di Benedetto R., et al. “Tyrosol, the major extra virgin olive oil compound, restored intracellular antioxidant defences in spite of its weak antioxidative effectiveness”. Nutrition, Metabolism and Cardiovascular Diseases7 (2007): 535-545.
  28. Salucci S., et al. “Tyrosol prevents apoptosis in irradiated keratinocytes”. Journal of Dermatological Science1 (2015): 61-68.
  29. Pacifici F., et al. “Tyrosol may prevent obesity by inhibiting adipogenesis in 3T3-L1 preadipocytes”. Oxidative Medicine and Cellular Longevity (2020).
  30. Gamli ÖF. “The health effects of oleuropein, one of the major phenolic compounds of olives (Olea europaea L)”. Italian Journal of Food Science 28 (2016): 178-189.
  31. Soler-Rivas C., et al. “Oleuropein and related compounds”. Journal of the Science of Food and Agriculture7 (2000): 1013-1023.
  32. Sun W., et al. “Oleuropein, unexpected benefits!” Oncotarget11 (2017): 17409-17409.
  33. Omar SH. “Oleuropein in olive and its pharmacological effects”. Scientia Pharmaceutica2 (2010): 133-154.
  34. Barbaro B., et al. “Effects of the olive-derived polyphenol oleuropein on human health”. International Journal of Molecular Sciences10 (2014): 18508-18524.
  35. Nediani C., et al. “Oleuropein, a bioactive compound from Olea europaea L., as a potential preventive and therapeutic agent in non-communicable diseases”. Antioxidants12 (2019): 578-604.
  36. De Bock M., et al. “Human absorption and metabolism of oleuropein and hydroxytyrosol ingested as olive (Olea europaea L.) leaf extract”. Molecular Nutrition and Food Research11 (2013): 2079-2085.
  37. Manna C., et al. “Oleuropein prevents oxidative myocardial injury induced by ischemia and reperfusion”. Journal of Nutritional Biochemistry 15 (2004): 461-466.
  38. Bulotta S., et al. “Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: Focus on protection against cardiovascular and metabolic diseases”. Journal of Translational Medicine 12 (2014): 219-227.
  39. Psaltopoulou T., et al. “Olive oil intake is inversely related to cancer prevalence: A systematic review and a meta-analysis of 13,800 patients and 23,340 controls in 19 observational studies”. Lipids in Health and Disease 10 (2011): 127-142.
  40. Hamdi HK and Castellon R. “Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor”. Biochemical and Biophysical Research Communications 334 (2005): 769-778.
  41. Cardeno A., et al. “Oleuropein, a secoiridoid derived from the olive tree, inhibits the proliferation of human colorectal cancer cell through down regulation fog HIF-1α”. Nutrition and Cancer1 (2013): 147-156.
  42. Shamshoum H., et al. “Anticancer effects of oleuropein”. Bio Factors4 (2017): 517-528.
  43. Han J., et al. “Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells”. Cytotechnology 59 (2009): 45-53.
  44. Kockar F., et al. “Determination of the anti-tumor effects of oleuropein in prostate (PC-3), breast (MCF-7) and hepatoma (HEP3B) cells”. Research Journal of Biological Sciences2 (2010): 185-190.
  45. Sudjana AN., et al. “Antimicrobial activity of commercial Olea europaea (olive) leaf extract”. International Journal of Antimicrobial Agents 33 (2009): 461-463.
  46. Scarmeas N., et al. “Mediterranean diet and risk for Alzheimer’s disease”. Annals of Neurology 59 (2006): 912-921.
  47. Cordero JG., et al. “Benefit of oleuropein aglycone for Alzheimer’s disease by promoting autophagy”. Oxidative Medicine and Cellular Longevity (2018): 1-12.
  48. Gouras GK., et al. “β-Amyloid peptides and amyloid plaques in Alzheimer's disease”. Neurotherapeutics1 (2015): 3-11.
  49. Martorell M., et al. “Potential therapeutic effects of oleuropein aglycone in Alzheimer's disease”. Current Pharmaceutical Biotechnology11 (2016): 994-1001.
  50. Butt MS., et al. “Neuroprotective effects of oleuropein: Recent developments and contemporary research”. Journal of Food Biochemistry12 (2021): e13967.
  51. Moosmann B and Behl C. “The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties”. Proceedings of the National Academy of Sciences of the United States of America 96 (1999): 8867-8872.
Citation: RE Carlson and JA von Fraunhofer. “The Biophenols behind the Mediterranean Diet”. EC Psychology and Psychiatry 11.7 (2022): 20-30.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

August Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the August issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before August 18, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.